Antares Pharma Price to Book Ratio 2006-2021 | ATRS

Historical price to book ratio values for Antares Pharma (ATRS) over the last 10 years. The current price to book ratio for Antares Pharma as of July 30, 2021 is 5.88.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Antares Pharma Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2021-07-30 4.40 5.88
2021-03-31 4.11 $0.75 5.50
2020-12-31 3.99 $0.71 5.59
2020-09-30 2.70 $0.39 6.90
2020-06-30 2.75 $0.35 7.97
2020-03-31 2.36 $0.32 7.26
2019-12-31 4.70 $0.33 14.25
2019-09-30 3.35 $0.27 12.29
2019-06-30 3.29 $0.25 12.91
2019-03-31 3.03 $0.26 11.54
2018-12-31 2.72 $0.24 11.14
2018-09-30 3.36 $0.15 21.72
2018-06-30 2.58 $0.16 16.49
2018-03-31 2.20 $0.18 12.22
2017-12-31 1.99 $0.21 9.29
2017-09-30 3.24 $0.23 14.08
2017-06-30 3.22 $0.26 12.50
2017-03-31 2.84 $0.27 10.66
2016-12-31 2.33 $0.29 8.00
2016-09-30 1.68 $0.32 5.31
2016-06-30 1.05 $0.35 2.99
2016-03-31 0.87 $0.39 2.25
2015-12-31 1.21 $0.43 2.79
2015-09-30 1.69 $0.47 3.60
2015-06-30 2.08 $0.50 4.16
2015-03-31 2.71 $0.27 10.16
2014-12-31 2.57 $0.31 8.22
2014-09-30 1.83 $0.38 4.78
2014-06-30 2.67 $0.43 6.28
2014-03-31 3.50 $0.49 7.13
2013-12-31 4.47 $0.55 8.14
2013-09-30 4.06 $0.58 6.99
2013-06-30 4.16 $0.63 6.65
2013-03-31 3.58 $0.66 5.40
2012-12-31 3.81 $0.69 5.54
2012-09-30 4.36 $0.33 13.41
2012-06-30 3.63 $0.32 11.26
2012-03-31 3.23 $0.31 10.46
2011-12-31 2.20 $0.30 7.31
2011-09-30 2.32 $0.30 7.77
2011-06-30 2.21 $0.30 7.27
2011-03-31 1.80 $0.12 14.65
2010-12-31 1.70 $0.08 21.60
2010-09-30 1.45 $0.08 17.34
2010-06-30 1.76 $0.10 18.26
2010-03-31 1.37 $0.10 14.09
2009-12-31 1.14 $0.11 10.54
2009-09-30 1.11 $0.13 8.30
2009-06-30 0.89 $0.04 20.99
2009-03-31 0.43 $0.07 6.04
2008-12-31 0.37 $0.11 3.48
2008-09-30 0.73 $0.14 5.11
2008-06-30 0.72 $0.18 3.90
2008-03-31 1.07 $0.22 4.83
2007-12-31 0.98 $0.27 3.67
2007-09-30 1.42 $0.28 5.12
2007-06-30 1.58 $0.10 15.46
2007-03-31 1.29 $0.10 12.60
2006-12-31 1.20 $0.10 12.59
2006-09-30 1.10 $0.11 10.14
2006-06-30 1.15 $0.14 8.09
2006-03-31 1.62 $0.18 9.06
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.743B $0.150B
Antares Pharma, Inc. develops, commercializes and markets novel delivery solutions, including needle-free and mini-needle injector systems, gel technologies and transdermal products, which improve both the efficiency of drug therapies and the quality of life for patients. The Company currently distributes its needle-free injector systems for the delivery of insulin and growth hormone in over 20 countries and an estradiol transdermal patch for hormone replacement therapy.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $74.377B 20.09
Align Technology (ALGN) United States $55.064B 79.25
McKesson (MCK) United States $32.243B 11.84
West Pharmaceutical Services (WST) United States $30.396B 58.82
Laboratory Of America Holdings (LH) United States $28.934B 8.74
Straumann Holding AG (SAUHF) Switzerland $28.671B 0.00
AmerisourceBergen (ABC) United States $25.095B 14.46
Cooper (COO) United States $20.771B 35.18
Cardinal Health (CAH) United States $17.229B 10.20
DENTSPLY SIRONA (XRAY) United States $14.418B 31.75
Henry Schein (HSIC) United States $11.277B 24.51
STAAR Surgical (STAA) United States $5.999B 290.73
CONMED (CNMD) United States $4.013B 45.08
Merit Medical Systems (MMSI) United States $3.925B 33.38
Patterson (PDCO) United States $3.016B 16.21
SmileDirectClub (SDC) United States $2.736B 0.00
Atrion (ATRI) United States $1.150B 37.28
Retractable Technologies (RVP) United States $0.400B 8.98
Invacare (IVC) United States $0.253B 0.00
Milestone Scientific (MLSS) United States $0.136B 0.00
Lifevantage (LFVN) United States $0.114B 8.29
Pro-Dex (PDEX) United States $0.112B 0.00
Biolase (BIOL) United States $0.086B 0.00